Gregory P Thill

Title: Innovations of Gregory P Thill

Introduction

Gregory P Thill is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the production of Bacillus entomotoxins and human serum albumin using methylotrophic yeast. With a total of 5 patents, his work has implications for both agricultural and medical applications.

Latest Patents

One of Thill's latest patents focuses on the production of Bacillus entomotoxins in methylotrophic yeast. This method involves culturing yeast cells that express Bacillus toxin polypeptides, which can be used as an insecticidal composition. The invention details how these toxin polypeptides can be expressed at high levels in transformed yeast cells, making them effective for killing susceptible insect larvae. Another significant patent involves the expression of human serum albumin in Pichia pastoris. This invention includes expression cassettes that facilitate the secretion of HSA, which is crucial for various therapeutic applications.

Career Highlights

Throughout his career, Gregory P Thill has worked with prominent organizations such as Research Corporation Technologies, Inc. and The Salk Institute Biotechnology Industrial Associates, Inc. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in biotechnology.

Collaborations

Thill has collaborated with notable individuals in his field, including Kathryn A Barr and Kotikanyadan Sreekrishna. These collaborations have further enriched his research and development efforts.

Conclusion

Gregory P Thill's innovative work in biotechnology, particularly in the production of Bacillus toxins and human serum albumin, showcases his significant contributions to the field. His patents reflect a commitment to advancing scientific knowledge and practical applications in agriculture and medicine.